Stock Ratings / Health Care / APT / insiders

MYO (33) COCH (35) NTRB (39) CNXU (43) ⌘ Pro Terminal →

Alpha Pro Tech Ltd. (APT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$5.40 -2.70% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $5.36

Alpha Pro Tech Ltd. (APT) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 62/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.7% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $56.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on APT Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Alpha Pro Tech Ltd. (NYSE: APT) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $5.40 (-2.70% 1D, market cap $56.6M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, APT ranks #167 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does APT compare to MYO and COCH in the Health Care sector?

▼

Within the Health Care sector (Industrial Specialties), APT carries a Roarable C (62/100 RQD), trailing P/E of 16.2x, gross margin of 38.1%, and ROIC of 6.7%. By comparison, MYO (Myomo Inc.) holds a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $51.5M) and COCH (Envoy Medical Inc. (Class A)) posts a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $50.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for APT?

▼

Per APT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884269), Alpha Pro Tech Ltd. generated $59.1M in revenue (+2.3% YoY), $3.5M in net income, and $1.7M in free cash flow against $74.1M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $5.36 (-0.68%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 2.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 62/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.7% avg 90D alpha vs SPY • 54.3% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+1.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for APT)Realized 20D OHLCV Swing Band: ±8.3%

Deterministic 5-Pillar Attribution (62/100 Composite)

🔍 WHY APT SCORES 62/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (26% of score)

Altman Z-Score 5.59 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (21% of score)

FRED Regime × Technicals: 34% of 52W Range • RSI-14 at 52.2 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$5.74-3.3% Next Q

Q2 (-2Q)

Grade B-$5.55-2% Next Q

Q3 (-1Q)

Grade C+$5.44-0.7% Next Q

Current

Grade C$5.40+0.7% Hist 90D α

Trajectory: B (70) → C (62)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the APT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 62/100 (C) score, APT faces multiple-compression risk if 16.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 35.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($5.40) or 200D SMA ($5.19) invalidates the momentum regime and cuts Target Base ($5.50) toward Bear Floor ($4.29).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $APT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “APT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 62%NO 38%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

APT Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (APT)

No recent open-market Form 4 cluster sales or emergency dumps flagged on APT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (APT Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

APT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +17.39%▲ ASCENDING CHANNEL

2026-11-02O $5.48H $5.55L $5.40C $5.40VOL 8.1K

RES: $6.44SUP: $5.06SMA50: $5.40SMA200: $5.19

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

APT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 APT Butterfly Map → + Track APT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.8%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on APT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for APT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for APT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (APT)

Health Care Rank #167 of 1016 ⚔️ MYO vs APT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (APT vs. MYO, COCH, NTRB, CNXU)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Alpha Pro Tech Ltd. (APT) ranks #167 by composite RQD confidence (62/100, grade C) and #731 by equity capitalization ($56.6M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently leads its immediate peer cohort in composite quantitative strength at 62/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
APT ACTIVE Alpha Pro Tech Ltd.	C	62/100	16.2x	38.1%	6.7%	-2.70%	$56.6M	Benchmark Subject
MYO Myomo Inc.	E	33/100	—	65.7%	-35.0%	-4.61%	$51.5M	/myo-vs-apt →
COCH Envoy Medical Inc. (Class A)	D-	35/100	—	-30.0%	-35.0%	+2.00%	$50.3M	/coch-vs-apt →
NTRB Nutriband Inc.	D-	39/100	—	27.8%	-35.0%	-5.12%	$80.7M	/ntrb-vs-apt →
CNXU Conexeu Sciences Inc.	D-	43/100	—	—	—	-10.25%	$85.8M	/cnxu-vs-apt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000884269

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alpha Pro Tech Ltd. (APT) reported GAAP revenue of $59.1M (+2.3% vs. FY2024 revenue of $57.8M ) , GAAP net income of $3.5M, operating cash flow of $2.4M, and free cash flow of $1.7M (-8.5% YoY). On the balance sheet, APT closed FY2025 with $74.1M in total assets against $0 in total debt (Altman Z-Score: 5.59, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$59.1M	$3.5M	$2.4M	$1.7M	$74.1M	—
FY2024 (FY)	2024-12-31	$57.8M	$3.9M	$5.7M	$1.9M	$73.7M	—
FY2023 (FY)	2023-12-31	$0	$4.2M	$8.5M	$8.5M	—	—

3. APT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does APT compare to MYO and COCH in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for APT?

Where is APT trading relative to its 50-day, 200-day, and 52-week technical levels?

APT last traded at $5.40 (-2.70% on volume of 29,207 shares), positioning the stock 0.00% above its 50-day simple moving average ($5.40) and +4.05% above its 200-day simple moving average ($5.19). Across its 52-week range of $4.34 to $7.50, APT sits at the 33.5% percentile with a 14-day RSI of 52.2 (NEUTRAL RANGE) and an implied next-earnings move of ±8.3% ($4.95 to $5.85).

APT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are APT insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies APT leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

Direct Sub-Reports: APT RQD Cockpit APT 12M Forecast APT Earnings & Move APT Dividends & DRIP APT Insiders & 13F APT Whale Options APT Profit Sankey APT News & Why

Sector Peer Dials

Envoy Medical Inc. (Class A)

Conexeu Sciences Inc.

43 /100

LAKE E

Lakeland Industries Inc.

APT Core Snapshot

Market Cap $56.6M

Trailing / Fwd P/E 16.2x / 15.1x

Gross Profit Margin 38.1%

Return on Capital (ROIC) 6.7%

Free Cash Flow Yield 3.06%

12M Base Price Target $5.50

FREE TRADER TOOLS

Own APT Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With APT → 🏆 Trade APT in $100K Prop Arena →

APT Wire

Why It Moved →

Direct Company Event Yahoo Finance • 14h ago

Zacks Initiates Coverage of APT With Neutral Recommendation

Peer / Ecosystem Wire Investing.com Nigeria • 17h ago

Form 4 ALPHA PRO TECH LTD: Donna Millar (Director, 10% Owner) For: 28 September

Direct Company Event Stock Traders Daily • 20h ago

Understanding the Setup: (APT) and Scalable Risk

Direct Company Event https://www.dars.gov.et/ • 23h ago

APT Q3 2025 Earnings: EPS of $0.09 as Shares Edge 1.28% Higher - Earnings Revision Upgrade

Peer / Ecosystem Wire Yahoo Finance • 179d ago

Alpha Pro Tech, Ltd. Announces First Quarter 2026 Financial Results

ROARABLE RATING BRIEF • RQD 62/100 (C) ✓ STAGE-C NUMBER FIREWALL VERIFIED

APT — Alpha Pro Tech Ltd.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:46:25Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, APT scores 62 out of 100, a letter grade of C, with the verdict "Roarable Hold — Fair / Balanced Risk-Reward." The five pillars are:

Fundamental Cash Engine (11 / 20): Per the Roarable RQD rating, the pillar reflects ROIC of 6.7% and an FCF yield of 3.06%. Modest returns on capital and a low free-cash-flow yield limit this pillar's contribution. For a prospective investor, the valuation case depends on whether cash generation can grow relative to the current market value.
Whale 13F Flow (9 / 20): Per the Roarable RQD rating, this pillar covers institutional accumulation and options positioning. It is the lowest-scoring pillar, suggesting limited evidence of institutional conviction in the source data.
Insider Conviction (13 / 20): Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. It is a moderate score, and the underlying trade-level detail is not included in the source data.
Macro Regime Fit (13 / 20): Per the Roarable RQD rating, beta is 1.0 and sector sensitivity is factored in. A beta of 1.0 implies market-level sensitivity to broad moves, neither dampening nor amplifying them.
Forensic Balance Sheet (16 / 20): Per the Roarable RQD rating, Altman Z is 5.59, Piotroski F is 5/9, and Debt/Equity is 0.5. This is the strongest pillar and indicates the balance sheet is a relative strength, which can cushion downside if operating results weaken.

Taken together, the balance-sheet strength and moderate valuation (per the market data, P/E TTM 16.2 and Forward P/E 15.1) are offset by weak institutional flow and modest capital returns. Upside drivers would need to come from improving ROIC and cash conversion; valuation tradeoffs center on paying roughly 15–16 times earnings for a business with a 6.5% operating margin.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
$5.55	$56.6M	16.2	15.1	9	0.34	0%	1.0	$4.34 - $7.5	6.7%

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$59.1M	$3.8M	$3.5M	N/A	$1.7M	$17.0M	N/A
FY 2024	$57.8M	$3.4M	$3.9M	N/A	$1.9M	$18.6M	N/A
FY 2023	$0.0M	$4.1M	$4.2M	N/A	$8.5M	N/A	N/A

Per the SEC financials, revenue rose from $57.8M in FY 2024 to $59.1M in FY 2025 while net income declined from $3.9M to $3.5M. Per the market data, operating margin is 6.5% and net margin is 5.9%, and ROIC is 6.7%. Per the Roarable RQD rating, the Altman Z-Score is 5.59 and the Piotroski F-Score is 5/9, with Debt/Equity at 0.5. Cash fell from $18.6M to $17.0M across the two most recent reported years.

Open Questions

What are the specific products and end markets behind the Industrial Specialties classification, and how is revenue distributed across them?
What drove the decline in net income from $3.9M in FY 2024 to $3.5M in FY 2025 while revenue rose?
What are the transaction details and size of the Form 4 filing referenced in the news wire?
What is the reported debt level, given that the FY debt fields are N/A despite a Debt/Equity of 0.5?
What explains the reported FY 2023 revenue of $0.0M alongside $8.5M of free cash flow?

APT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Alpha Pro Tech Ltd. (APT) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to APT Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 14h ago

Zacks Initiates Coverage of APT With Neutral Recommendation

Yahoo Finance report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com Nigeria • 17h ago

Form 4 ALPHA PRO TECH LTD: Donna Millar (Director, 10% Owner) For: 28 September

Investing.com Nigeria report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Traders Daily • 20h ago

Understanding the Setup: (APT) and Scalable Risk

Stock Traders Daily report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST https://www.dars.gov.et/ • 23h ago

APT Q3 2025 Earnings: EPS of $0.09 as Shares Edge 1.28% Higher - Earnings Revision Upgrade

https://www.dars.gov.et/ report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 179d ago

Alpha Pro Tech, Ltd. Announces First Quarter 2026 Financial Results

First Quarter Net Sales Increased by 5.5% to $14.6 Million, Compared to $13.8 Million for the First Quarter of 2025 Net sales for the first quarter of 2026 were $14.6 million, up 5.5% compared to $13.8 million for the fi

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 45d ago

Aptos launches Confidential APT on mainnet

Aptos has taken its optional privacy feature live, allowing users to encrypt APT balances and transfer amounts while keeping wallet addresses visible.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 28d ago

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 88d ago

Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results

Second Quarter Net Sales Increased by 12% to $18.7 Million from $16.7 Million in the Second Quarter of 2025; Second Quarter Net Income Increased by 47% to $1.8 Million from $1.2 Million in the Prior Year Period Net sales

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

APT Bull vs. Bear Conversation Board — What's Your Call at $5.40?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON APT 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $5.99 (+7.9%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is APT (C • RQD 62/100) a Buy at $5.55?

Welcome to the APT (Alpha Pro Tech Ltd.) Roar Pit. Current RQD Composite is 62/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Industrial Specialties. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $4.50 (-18.9%)

Spot @ $5.55

Pump the brakes on APT — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on APT, but look at what you are paying: 16.2x trailing P/E with 38.1% gross margins. Unless Alpha Pro Tech Ltd. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader 🐂 BULLISH 🎯 Target: $6.77 (+22.0%)

Spot @ $5.55

APT cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on APT, the market is fixating on short-term headline noise in Industrial Specialties and ignoring the balance sheet and cash flow trajectory. At $5.55 (52-wk range $4.34 - $7.50), any beat on forward guidance forces shorts and underweight funds to chase.